Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Oropharyngeal Cancer”

351 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 351 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06234748
What this trial is testing

Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer

Who this might be right for
Oropharynx CancerHPV-Related Carcinoma
University of Michigan Rogel Cancer Center 19
Testing effectiveness (Phase 2)Study completedNCT00020189
What this trial is testing

Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck CancerThromboembolism
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)WithdrawnNCT04001413
What this trial is testing

Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients

Who this might be right for
HPV Positive Oropharyngeal Squamous Cell CarcinomaOropharynx CancerHPV-Related Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT01585428
What this trial is testing

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers

Who this might be right for
Cervical CancerOropharyngeal CancerVaginal Cancer+2 more
National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)Study completedNCT00851877
What this trial is testing

Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University of Texas Southwestern Medical Center 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT03383094
What this trial is testing

Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaCancerCancer of Head and Neck+12 more
Loren Mell, MD 126
Testing effectiveness (Phase 2)WithdrawnNCT04044950
What this trial is testing

A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal Cancer

Who this might be right for
Papillomavirus InfectionsOropharyngeal Neoplasms
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT00002476
What this trial is testing

Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Cancer Research UK
Testing effectiveness (Phase 2)Study completedNCT00248560
What this trial is testing

Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Barbara Ann Karmanos Cancer Institute 36
Testing effectiveness (Phase 2)Study completedNCT01044433
What this trial is testing

Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck

Who this might be right for
Head and Neck CancerMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult Primary+17 more
Abramson Cancer Center at Penn Medicine 44
Large-scale testing (Phase 3)Study completedNCT00765440
What this trial is testing

Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive Tract

Who this might be right for
Head and Neck CancerInfectionMalnutrition
Centre Antoine Lacassagne 311
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06728618
What this trial is testing

Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Oral Squamous Cell Carcinoma (OSCC)Oropharyngeal Squamous Cell Carcinoma (SCC)Resectable Oral and Oropharyngeal Squamous Cell Carcinoma+1 more
Shanghai Zhongshan Hospital
Large-scale testing (Phase 3)Active Not RecruitingNCT03952585
What this trial is testing

De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer

Who this might be right for
Basaloid Squamous Cell CarcinomaClinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01256385
What this trial is testing

Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy

Who this might be right for
Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+33 more
National Cancer Institute (NCI) 86
Testing effectiveness (Phase 2)Study completedNCT00096174
What this trial is testing

Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
Eastern Cooperative Oncology Group 69
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07058805
What this trial is testing

Compartmentalized Postoperative Radiotherapy in Head and Neck Cancer

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell CarcinomaOral Cavity Squamous Cell Carcinoma+3 more
Olgun Elicin 50
Testing effectiveness (Phase 2)Ended earlyNCT04106362
What this trial is testing

Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With HPV Positive, KRAS-Variant Stage III-IV Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8KRAS Protein Variant+2 more
Jonsson Comprehensive Cancer Center 1
Large-scale testing (Phase 3)Active Not RecruitingNCT03811015
What this trial is testing

Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer

Who this might be right for
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
National Cancer Institute (NCI) 636
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07178301
What this trial is testing

Evaluating a Decreased Dose of Radiation Therapy to the Elective Neck for the Treatment of HPV-Related Oropharyngeal Cancer, ENLIGHT Trial

Who this might be right for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Northwestern University 100
Early research (Phase 1)Study completedNCT00031681
What this trial is testing

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more
National Cancer Institute (NCI) 41
Load More Results
28
384